EA
EW icon

Edge Advisors’s Edwards Lifesciences EW Stock Holding History

Edge Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$140K Hold
2,910
– – 0.01% 359
2018
Q1 		$134K Hold
2,910
– – 0.01% 368
2017
Q4 		$109K Hold
2,910
– – 0.01% 382
2017
Q3 		$105K Hold
2,910
– – 0.01% 381
2017
Q2 		$114K Hold
2,910
– – 0.01% 379
2017
Q1 		$90K Sell
2,910
-645
-18% -$20.2K 0.01% 421
2016
Q4 		$110K Buy
+3,555
New +$115K 0.01% 365

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Edge Advisors's EW Position: Q2 2018 in Review

Edge Advisors held its Edwards Lifesciences (EW) position steady in Q2 2018 at 2,910 shares worth $140K. The position accounts for 0.01% of the portfolio, ranked #359.

Edge Advisors first reported a position in EW in Q4 2016 and has held it in 7 quarters since. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

  • Edge Advisors held 2,910 shares of Edwards Lifesciences worth $140K as of Q2 2018.
  • Edge Advisors left its Edwards Lifesciences share count unchanged in Q2 2018.
  • Edwards Lifesciences made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #359 holding.
  • Edge Advisors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 7 quarters since.
  • 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.